StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > QUIET HERE

<< Previous

Bullboard Posts

Next >>

Comment by JACKTHEBEAR2on Mar 24, 2021 2:58pm

102 Views

Post# 32868132

RE:RE:QUIET HERE

If Tripp misses and doesn't announce then the result will be a kick in the teeth to not only LT shareholders but the price will greatly be effected . That could explain the lull we find ourselves in. It can all change just have to wait until mon.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?